Infection Current Awareness Update 31/01/2022
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Infection Current Awareness Update – 31/01/2022
Welcome to the weekly Infection Current Awareness Update (ICAU), produced by UKHSA
Knowledge and Library Services. The purpose of this update is to provide you with the latest,
best evidence about infection, to help you make informed decisions.
Please note: UKHSA KLS has set up a separate COVID-19 Daily Alert of latest research. If
you would like to receive this, please email libraries@phe.gov.uk. In addition to this, a page of
resources about the coronavirus is available here.
If you have any queries, please contact us at libraries@phe.gov.uk, and if you would like to
request a literature search, please use the Knowledge and Library Services Enquiries Portal.
Please note that not all the articles and resources referred to in this alert are freely available.
Some articles may require an Athens username and password. For further information on
Athens accounts please visit here. If you are not eligible to access our library services, then
you may want to approach your local NHS library service.
We do not accept responsibility for the availability or reliability of the items of content
included in this alert and their inclusion is not an endorsement of any views that may
be expressed.
Infection-related guidance
• European Centre for Disease Prevention and Control - 1
• Healthcare Infection Society - 1
Infection-related journals
• American Journal of Infection Control - 22
• Clinical Infectious Diseases - Advance Access - 20
• Clinical Infectious Diseases - Current Issue - 34
• Clinical Microbiology and Infection - 2
• Diagnostic Microbiology and Infectious Disease - 1
• Emerging Infectious Diseases Journal - ahead of print - 3
• Eurosurveillance latest updates - 6
• Hepatology - 2
• Infection - 6
• International Journal of Medical Microbiology - 2
• Infection Control & Hospital Epidemiology - FirstView Article - 3
• International Journal of Infectious Diseases - 9
• Journal of Clinical Microbiology - 1
• Journal of Hospital Infection - 3
• Journal of Infection - 8
• Journal of Infectious Diseases - 25
• Journal of Virology Current Issue - 8
• Journal of Virology: Articles Published Ahead of Print - 4
• Lancet: Infectious Diseases - 20• Morbidity and Mortality Weekly Report (MMWR) - 8
• Nature Reviews Microbiology - Current Issue - 4
• New England Journal of Medicine - Current Issue - 6
• Scandinavian Journal of Infectious Diseases: Table of Contents - 2
• Sexually Transmitted Infection Online First - 1
NIS Affiliation
• PubMed: NIS affiliation - 5
Infection-related guidance
European Centre for Disease Prevention and Control
Influenza virus characterisation - Summary Europe, December 2021
25 Jan 2022
This is the third report for the 2021-2022 influenza season. As of week 52/2021, 23 246
influenza detections across the WHO European Region were reported to TESSy.
[back to top]
Healthcare Infection Society
Automated room decontamination: report of a Healthcare Infection
Society Working Party [PDF]
28 Jan 2022
Current < 3 years
[back to top]
Infection-related journals
American Journal of Infection Control
Healthcare Worker Feedback on Duodenoscope Reprocessing
Workflow and Ergonomics
30 Jan 2022
Duodenoscopes are orally inserted endoscopes that are used to inspect the duodenum and
access the common bile duct or pancreatic duct during endoscopic retrograde
cholangiopancreatography (ERCP) procedures. Duodenoscopes have a complex design; the
devices have long, narrow channels and a distal elevator recess that incorporates a user-
controlled forceps elevator.
SARS-CoV-2 RNA persists on surfaces following terminal disinfection
of COVID-19 hospital isolation rooms
30 Jan 2022
While uncommon under rigorous infection control measures, nosocomial SARS-CoV-2
infection has been reported among hospitalized patients.1, 2 SARS-CoV-2 transmission
occurs primarily via respiratory droplets and aerosols but may also occur secondarily via
fomites, given virus stability on certain surfaces.3 This emphasizes the importance of
effective surface decontamination in healthcare settings
Treatment of Extensively-drug Resistant (XDR) Acinetobacter and
Impact on Clinical Outcomes in U.S. Veterans Affairs (VA) Medical
Centers
30 Jan 2022: Guidelines for treatment of resistant Gram-negative infections do not include Acinetobacter baumannii (AB), leaving a knowledge gap in best practices for treatment. This study described treatments and outcomes of extensively-drug resistant (XDR) AB. Hand hygiene performance in an intensive care unit before and during the COVID-19 pandemic 30 Jan 2022 Hand hygiene is an important measure for the safety of healthcare workers (HCWs) and patients1 and monitoring the hand hygiene adherence and providing feedback to HCWs is recommended by the Centers for Disease Control and Prevention2. INFECTION PREVENTION AND CONTROL PROGRAM ASSESSMENT TOOLS: A COMPARATIVE STUDY 30 Jan 2022 : Infection prevention and control program (IPCP) assessment tools help to identify the improvement needs. This study aimed to identify fit-for-purpose of three IPCP assessment tools. Impact of a dental care intervention on the hospital mortality of critically ill patients admitted to intensive care units: a quasi-experimental study 29 Jan 2022 The respiratory system is one of the most affected by hospital-acquired infections1-3. These infections are often associated with the death of intensive care patients2-5. Although the development of preventive strategies has increasingly reduced the incidence of ventilator- associated pneumonia (VAP)4-9, this healthcare-associated infection is still an important cause of morbidity and mortality in Peripherally Inserted Central Catheter-Related Bloodstream Infections in Patients with Hematological Malignancies: a Retrospective 7-Years Single-Center Study 29 Jan 2022 Utilization of central venous catheter plays an important role in managing patients with hematological malignancies in health care facilities1,2. An easy and safe strategy to manage intravenous line may be necessary due to the limited availability of peripheral veins, in order to achieve a better administration of chemotherapy, blood transfusions, parenteral nutrition, and other supportive Sporadic outbreaks of healthcare-associated COVID-19 infection in a highly-vaccinated inpatient population during a community outbreak of the B.1.617.2 variant: the role of enhanced infection-prevention measures 29 Jan 2022 Infection-prevention measures in healthcare settings may mitigate transmission of severe- acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2), resulting in lower secondary- attack-rates compared to community settings.1 However, novel variants with higher transmissibility, including the SARS-CoV-2 delta variant (B.1.617.2), challenge containment efforts Prevalence and incidence of tuberculosis in health workers: a systematic review of the literature 29 Jan 2022 Among infectious diseases, tuberculosis (TB) is a public health problem and an important focus of attention mainly in low and middle-income countries. The occurrence of this disease has been recorded in different historical periods, but it is still a challenge today Transitional impact on Acinetobacter baumannii MDR infections in 5 Brazilian ICUs in 2020 28 Jan 2022 We read the interesting study published by Polly et al,1 which found a significant difference in the multidrug-resistant (MDR) infection incidence during the Coronavirus pandemic (COVID- 19) in a Brazilian Intensive Care Unit (ICU)
The patient engagement in education and research (PEER) healthcare-
associated infection prevention project: A patient perspective
28 Jan 2022
My comments are related to the original research entitled “Engaging Veterans in Identifying
Key Elements of Environmental Cleaning and Disinfection for Preventing Healthcare-
Associated Infections: A Qualitative Study.”
Increasing legionella in Taiwan during COVID-19 pandemic
28 Jan 2022
We read with great interest the recent study by Liang et al,1 which demonstrated that
prolonged building closures due to coronavirus disease 2019 (COVID-19) pandemic caused
extreme stagnation in building water systems, which could further significantly increase the
presence of Legionella
Table of Contents
28 Jan 2022
Information for Readers
28 Jan 2022
Looking back to move forward
28 Jan 2022
First and foremost, congratulations to APIC on its 50th anniversary and AJIC's 50th volume!
When AJIC Editor Stone invited me to join AJIC's year-long celebration of these milestones
by reviewing some of the highlights during my 25 years as AJIC editor, I was delighted to
accept
Impact of the COVID-19 pandemic on the incidence of multidrug-
resistant bacterial infections in an acute care hospital in Brazil
28 Jan 2022
We appreciate the contribution of Lima et al to the discussion of this important issue. While
their results appear different, it is important to appreciate the numerous differences in our
methodologies when making that comparison
The patients engaged in education and research (PEER) health care-
associated infection prevention project: A Veteran perspective
28 Jan 2022
My involvement in Veteran research began about 10-15 years ago through researchers at
the Medical College of Wisconsin (MCW) and the Milwaukee VA. They were interested in
Dryhootch of America, where I served as Cofounder and Director of Community Programs
and Peer Coordinator
Engaging veterans in identifying key elements of environmental
cleaning and disinfection for preventing healthcare-associated
infections: A qualitative study
28 Jan 2022
Participatory research has been found to be beneficial throughout the research life cycle:
from improving research recruitment and response to progressing research perspectives,
planning, processes and outcomes
Editorial Board
28 Jan 2022
APIC Masthead
28 Jan 2022
Information for Authors
28 Jan 2022
Assessment of the Effect of Hand Dryers Used in Shopping Malls on
Hand Hygiene
24 Jan 2022
Hand washing is defined as washing hands with regular soap or antimicrobial soap, ranging
from briefly rinsing to intensely scrubbing the hands and drying properly. Hand washing is
critical in fighting infectious diseases since hands contaminated with pathogens play a
significant role in microbial transmission1,2
[back to top]Clinical Infectious Diseases - Advance Access Prevalence and Correlates of Viral Load Suppression and HIV Drug Resistance Among Children and Adolescents in South Rift Valley and Kisumu, Kenya 29 Jan 2022 Itraconazole and voriconazole: the complexity of dose adjustments 29 Jan 2022 Pediatric Hospitalizations after School Reopening during the SARS- CoV-2 Alpha (B.1.1.7) Variant Spread: A Multicenter Cross-sectional Study in Israel 29 Jan 2022 Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 —United States, January–April 2021 29 Jan 2022 Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants 29 Jan 2022 Reply to author 29 Jan 2022 Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort 28 Jan 2022 Surveillance for Disseminated Gonococcal Infections, Active Bacterial Core surveillance (ABCs) – United States, 2015–2019 28 Jan 2022 Gut dysfunction markers are associated with body composition in youth living with perinatally acquired HIV 28 Jan 2022 Mass drug administration for the control of scabies: a systematic review and meta-analysis 28 Jan 2022 The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 – September 2021 27 Jan 2022 Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 27 Jan 2022 Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study 27 Jan 2022 Vaccination in Prisons and Jails: Corrections Needed in Future Plans 27 Jan 2022 Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living
With HIV-1: Results Through Week 144 From the Phase 3, Non-
inferiority TANGO Randomized Trial
25 Jan 2022
Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and
its Application in Household Investigation
25 Jan 2022
Detection of Treponema pallidum DNA during early syphilis stages in
peripheral blood, oropharynx, ano-rectum and urine as a proxy for
transmissibility
25 Jan 2022
SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal
Human Coronaviruses
25 Jan 2022
Fever of unknown origin and incidence of cancer
25 Jan 2022
Erratum to: A Novel Human Acute Encephalitis Caused by
Pseudorabies Virus Variant Strain
24 Jan 2022
[back to top]
Clinical Infectious Diseases - Current Issue
Tracing People Living With Human Immunodeficiency Virus Who Are
Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa:
A Sampling-Based Cohort Study in 6 Countries
30 Jan 2022
Marie Ballif, Benedikt Christ, Nanina Anderegg, Frédérique Chammartin, Josephine
Muhairwe ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 171–
179, https://doi.org/10.1093/cid/ciab428 A sampling-based approach to tracing clients lost to
follow-up can lead to a better understanding of the outcomes in those lost to follow-up and
inform interventions tailored to
Efficacy, Safety and Tolerability of Pyronaridine-artesunate in
Asymptomatic Malaria-infected Individuals: a Randomized Controlled
Trial
30 Jan 2022
Edgard D Dabira, Sebastian Hachizovu, Bakary Conteh, Alieu Mendy, Haddy Nyang ...
Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 180–188,
https://doi.org/10.1093/cid/ciab425 This randomized study in The Gambia and Zambia
evaluated pyronaridine-artesunate as full or incomplete treatment in individuals with
asymptomatic Plasmodium falciparum infection
Pertussis Immunization During Pregnancy: Assessment of the Role of
Maternal Antibodies on Immune Responses in Term and Preterm-Born
Infants
30 Jan 2022
Kirsten Maertens, Marjolein R P Orije, Sereina A Herzog, Ludo M Mahieu, Niel Hens ...
Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 189–198,
https://doi.org/10.1093/cid/ciab424 Preterm infants profit from maternal Tdap vaccination.
Vaccination earlier in pregnancy is better to protect both term and preterm infants
SARS-CoV-2 RNAemia Predicts Clinical Deterioration and
Extrapulmonary Complications from COVID-19
30 Jan 2022
Nikhil Ram-Mohan, David Kim, Elizabeth J Zudock, Marjan M Hashemi, Kristel C Tjandra ...
Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 218–226,https://doi.org/10.1093/cid/ciab394 Measurement of severe acute respiratory syndrome coronavirus 2 RNA from the plasma of patients with coronavirus disease 2019, using digital polymerase chain reaction, can predict disease The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions 30 Jan 2022 Justin R Ortiz, Stephen L Yu, Amanda J Driscoll, Sarah R Williams, Joanie Robertson ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 227–236, https://doi.org/10.1093/cid/ciab393 We investigated the operational feasibility of preseasonal influenza vaccination campaigns in countries in World Health Organization (WHO) African and South-East Asian Regions Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection 30 Jan 2022 Manish C Choudhary, Charles R Crain, Xueting Qiu, William Hanage, Jonathan Z Li Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 237–245, https://doi.org/10.1093/cid/ciab380 Reinfecting SARS-CoV-2 viral genomes largely mirror contemporaneous circulating sequences in that geographic region, while persistent COVID- 19 has been largely described in immunosuppressed individuals Comparative 1-Year Outcomes of Invasive Staphylococcus aureus Infections Among Persons With and Without Drug Use: An Observational Cohort Study 30 Jan 2022 Ayesha Appa, Meredith Adamo, Stephenie Le, Jennifer Davis, Lisa Winston ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 263–270, https://doi.org/10.1093/cid/ciab367 Persons who use drugs (PWUD) with invasive Staphylococcus aureus infections had lower rates of antibiotic completion and twice the risk of 1-year infection persistence/recurrence compared to non-PWUD Retrospective Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Symptomatic Patients Prior to Widespread Diagnostic Testing in Southern California 30 Jan 2022 Evann E Hilt, James Boocock, Marisol Trejo, Catherine Q Le, Longhua Guo ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 271–277, https://doi.org/10.1093/cid/ciab360 We conducted a study of retrospective detection and sequencing of SARS-CoV-2 in symptomatic patients that reveals introduction in Los Angeles from both domestic and international sources in middle to late Development and Validation of the Long Coronavirus Disease (COVID) Symptom and Impact Tools: A Set of Patient-Reported Instruments Constructed From Patients’ Lived Experience 30 Jan 2022 Viet-Thi Tran, Carolina Riveros, Bérangère Clepier, Moïse Desvarieux, Camille Collet ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 278–287, https://doi.org/10.1093/cid/ciab352 We developed the long COVID Symptom and Impact Tools from the experiences of 492 patients, captured during a survey with open-ended questions, and assessed their validity and reliability in a Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing 30 Jan 2022 Adnan I Qureshi, William I Baskett, Wei Huang, Iryna Lobanova, S Hasan Naqvi ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 294–300, https://doi.org/10.1093/cid/ciab345 Reinfection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) was infrequent, occurring in 63 (0.7%) of 9119 patients but was associated with 2 deaths Mortality Trends in Risk Conditions and Invasive Mycotic Disease in the United States, 1999–2018 30 Jan 2022 Emily Rayens, Karen A Norris, José F Cordero Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 309–318, https://doi.org/10.1093/cid/ciab336 Mortality for individuals at risk of invasive fungal infections, as well as those with fungal diagnoses, has risen over the past 20 years Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in a Georgia School District—United States, December 2020–January 2021 30 Jan 2022 Jenna R Gettings, Jeremy A W Gold, Anne Kimball, Kaitlin Forsberg, Colleen Scott ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 319–326, https://doi.org/10.1093/cid/ciab332 We assessed severe acute respiratory syndrome coronavirus 2 transmission in a Georgia school district using in-depth epidemiologic investigations and whole-genome sequencing Substantial Decline in Invasive Pneumococcal Disease During Coronavirus Disease 2019 Pandemic in Hong Kong 30 Jan 2022 Jade L L Teng, Kenny M N Fok, Ken P K Lin, Elaine Chan, Yuanchao Ma ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 335–338, https://doi.org/10.1093/cid/ciab382 Abstract View article Supplementary data Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru 30 Jan 2022 Marco Tovar, Jesús Peinado, Santiago Palomino, Fernando Llanos, Claudio Ramírez ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 343–346, https://doi.org/10.1093/cid/ciab323 Abstract View article Reply to Lapadula et al 30 Jan 2022 Rebecca N Kumar, En-Ling Wu, Valentina Stosor, William J Moore, Chad Achenbach ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 363–364, https://doi.org/10.1093/cid/ciab468 Extract View article A Link Between Obesity and Coronavirus Disease 2019 30 Jan 2022 Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages i–ii, https://doi.org/10.1093/cid/ciac016 Extract View article Role of Epithelial–Endothelial Cell Interaction in the Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection 30 Jan 2022 Kenrie Pui-Yan Hui, Man-Chun Cheung, Ka-Ling Lai, Ka-Chun Ng, John Chi-Wang Ho ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 199–209, https://doi.org/10.1093/cid/ciab406 Soluble mediators from severe acute respiratory syndrome coronavirus 2–infected epithelial cells induced proinflammatory responses and adhesion molecules in pulmonary microvascular endothelial cells Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States 30 Jan 2022 Mehlika Toy, David Hutton, Aaron M Harris, Noele Nelson, Joshua A Salomon ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 210–217, https://doi.org/10.1093/cid/ciab405 Universal hepatitis B surface antigen screening of adults for chronic hepatitis B in the United States is likely cost-saving and will result in better health outcomes compared with current practice if
Menstrual Toxic Shock Syndrome: A French Nationwide Multicenter Retrospective Study 30 Jan 2022 Damien Contou, Gwenhaël Colin, Brendan Travert, Sébastien Jochmans, Marie Conrad ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 246–253, https://doi.org/10.1093/cid/ciab378 None of the patients with menstrual toxic shock syndrome required limb amputation or died despite a high rate of vasopressor support and invasive mechanical ventilation Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology 30 Jan 2022 Andrew H Karaba, Weiqiang Zhou, Leon L Hsieh, Alexis Figueroa, Guido Massaccesi ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 254–262, https://doi.org/10.1093/cid/ciab376 Severe COVID-19 is marked by dysregulated inflammation and is associated with elevated BMI Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya 30 Jan 2022 Anthony O Etyang, Ruth Lucinde, Henry Karanja, Catherine Kalu, Daisy Mugo ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 288–293, https://doi.org/10.1093/cid/ciab346 In this study of antibodies to severe acute respiratory syndrome coronavirus 2 among healthcare workers in 3 counties in Kenya, we found significant regional differences in seroprevalence but no Medium-Term Outcomes in Severely to Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection 30 Jan 2022 Nandan Gautam, Shyam Madathil, Natascia Tahani, Shaun Bolton, Dhruv Parekh ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 301–308, https://doi.org/10.1093/cid/ciab341 A case series of 200 patients hospitalised with severe-to- critical COVID-19 found persisting breathlessness and fatigue in over half of cases 4-7 months post disease-onset, with higher comorbidities, Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients 30 Jan 2022 Juanjie Tang, Gabrielle Grubbs, Youri Lee, Hana Golding, Surender Khurana Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 327–334, https://doi.org/10.1093/cid/ciab317 Our study demonstrated that convalescent plasma transfusion had no impact on clinical outcome of severe COVID-19 patients (survival vs. demise) Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Patient Transport Van 30 Jan 2022 Lucas D Jones, Ernest R Chan, Trina F Zabarsky, Jennifer L Cadnum, Maria E Navas ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 339–342, https://doi.org/10.1093/cid/ciab347 Abstract View article Supplementary data Premarket Development Times for Innovative Vaccines––To What Extent Are the Coronavirus Disease 2019 (COVID-19) Vaccines Outliers? 30 Jan 2022 Reed F Beall, Aaron S Kesselheim, Aidan Hollis Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 347–351, https://doi.org/10.1093/cid/ciab389 Despite their perceived speed-to-market, coronavirus disease 2019 (COVID-19) vaccines have had underlying technology in development for many years
Are Some COVID-19 Vaccines Better Than Others? Interpreting and
Comparing Estimates of Efficacy in Vaccine Trials
30 Jan 2022
Rekha R Rapaka, Elizabeth A Hammershaimb, Kathleen M Neuzil Clinical Infectious
Diseases, Volume 74, Issue 2, 15 January 2022, Pages 352–358,
https://doi.org/10.1093/cid/ciab213 COVID-19 vaccine trials provide valuable insight into the
safety and efficacy of vaccines. Simple comparison of trial efficacy estimates, however, is
problematic
A Case of Persistent Aortic Graft and Retroperitoneal Enhancement on
FDG PET/CT
30 Jan 2022
Marwa Sabha, Anton Gryaznov, Romana Mayer, Allen Burke, James B Doub Clinical
Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 359–362,
https://doi.org/10.1093/cid/ciab297 Extract View article
Beware of Biases in Observational Studies on Anti-Spike Monoclonal
Antibodies
30 Jan 2022
Giuseppe Lapadula, Davide Paolo Bernasconi, Alessandro Soria, Maria Grazia Valsecchi,
Paolo Bonfanti Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Page 363,
https://doi.org/10.1093/cid/ciab467 Extract View article
O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful
in Reducing Morbidity, Mortality, and Antimicrobial Resistance
30 Jan 2022
Guilhem Royer, Olivier Clermont, Bénédicte Condamine, Mélanie Mercier-Darty, Cédric
Laouénan ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 364–
366, https://doi.org/10.1093/cid/ciab458 Extract View article
Neutralization of Variant Under Investigation B.1.617.1 With Sera of
BBV152 Vaccinees
30 Jan 2022
Pragya D Yadav, Gajanan N Sapkal, Priya Abraham, Raches Ella, Gururaj Deshpande ...
Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 366–368,
https://doi.org/10.1093/cid/ciab411 Extract View article
Is 3 Feet of Physical Distancing Enough?
30 Jan 2022
Daniel A Harris, Mercedes Sobers, Zoë R Greenwald, Alison E Simmons, Jean-Paul R
Soucy ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Pages 368–
370, https://doi.org/10.1093/cid/ciab439 Extract View article
Reply to Author
30 Jan 2022
Westyn Branch-Elliman, Rebecca S Jack, Elissa M Schechter-Perkins, Polly van den Berg,
Isabella Epshtein ... Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022,
Pages 370–371, https://doi.org/10.1093/cid/ciab440 Extract View article
Corrigendum to: Effectiveness of the 7- and 13-Valent Pneumococcal
Conjugate Vaccines Against Vaccine-Serotype Otitis Media
30 Jan 2022
Ron Dagan, Bart Adriaan Van Der Beek, Shalom Ben-Shimol, Tamara Pilishvili, Noga Givon-
Lavi Clinical Infectious Diseases, Volume 74, Issue 2, 15 January 2022, Page 372,
https://doi.org/10.1093/cid/ciab806 Extract View article
Erratum to: Deaths Attributable to Cancer in the US Human
Immunodeficiency Virus Population During 2001–2015
30 Jan 2022
Marie-Josèphe Horner, Meredith S Shiels, Ruth M Pfeiffer, Eric A Engels Clinical Infectious
Diseases, Volume 74, Issue 2, 15 January 2022, Page 373,
https://doi.org/10.1093/cid/ciab805 Extract View article
[back to top]Clinical Microbiology and Infection
Corrigendum to “Seroprevalence of SARS-CoV-2 in 1922 blood donors
from the Lodi Red Zone and adjacent Lodi metropolitan and suburban
area”, Clin Microbiol Infect 2021 Jun;27(6):914.e1-914.e4
25 Jan 2022
Publication date: Available online 25 January 2022Source: Clinical Microbiology and
InfectionAuthor(s): Irene Cassaniti, Elena Percivalle, Antonella Sarasini, Giuseppe Cambiè,
Edoardo Vecchio Nepita, Roberta Maserati, Alessandro Ferrari, Alfonso Corcione, Raffaella
Di Martino, Alice Bonetti, Annapia Di Napoli, Guglielmo Ferrari, Fausto Baldanti
Accelerating clinical trial implementation in the context of the COVID-19
pandemic
25 Jan 2022
Publication date: Available online 25 January 2022Source: Clinical Microbiology and
InfectionAuthor(s): Andrzej Jan Rys, Irene Norstedt
[back to top]
Diagnostic Microbiology and Infectious Disease
Diagnostic performance of two serological assays for the detection of
SARS-CoV-2 specific antibodies: surveillance after vaccination.
26 Jan 2022
Publication date: Available online 26 January 2022Source: Diagnostic Microbiology and
Infectious DiseaseAuthor(s): Alba Fresco-Taboada, Marga García-Durán, Cristina Aira,
Lissett López, Patricia Sastre, Lia van der Hoek, Marit J. van Gils, Philip J.M. Brouwer,
Rogier W. Sanders, Barbara Holzer, Irene Zimpernikc, Eduardo López-Collazo, Patricia
Muñoz, Paloma Rueda, Carmen Vela
[back to top]
Emerging Infectious Diseases Journal - ahead of print
High-Dose Convalescent Plasma for Treatment of Severe COVID-19
26 Jan 2022
G. C. De Santis et al.
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough
County, Florida, October 2020–March 2021
26 Jan 2022
A. R. Giuliano et al.
Association of Healthcare and Aesthetic Procedures with Infections
Caused by Nontuberculous Mycobacteria, France, 2012‒2020
03 Dec 2021
C. Daniau et al.
[back to top]
Eurosurveillance latest updates
Surveillance of leishmaniasis cases from 15 European centres, 2014 to
2019: a retrospective analysis
27 Jan 2022
Background Surveillance of human leishmaniasis in Europe is mostly limited to country-
specific information from autochthonous infections in the southern part. As at the end of
2021, no integrated analysis has been performed for cases seen across centres in different
European countriesIs clinical primary care surveillance for tularaemia a useful addition to
laboratory surveillance? An analysis of notification data for Finland,
2013 to 2019
27 Jan 2022
Background In Finland, surveillance of tularaemia relies on laboratory-confirmed case
notifications to the National infectious Diseases Register (NIDR). Aim The aim of the study
was to assess the suitability and usefulness of clinical surveillance as an addition to
laboratory notification to improve tularaemia surveillance in Finland
Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared
with Delta in vaccinated and previously infected individuals, the
Netherlands, 22 November 2021 to 19 January 2022
27 Jan 2022
Infections with the Omicron SARS-CoV-2 variant are rapidly increasing worldwide. Among
174,349 SARS-CoV-2-infected individuals (≥ 12 years), we observed an increased risk of S
gene target failure, predictive of the Omicron variant, in vaccinated (odds ratio (OR): 3.6;
95% confidence interval (CI): 3.4–3.7) and previously infected individuals (OR: 4.2; 95% CI:
3.8–4
Reduced risk of hospitalisation among reported COVID-19 cases
infected with the SARS-CoV-2 Omicron BA.1 variant compared with the
Delta variant, Norway, December 2021 to January 2022
27 Jan 2022
We included 39,524 COVID-19 Omicron and 51,481 Delta cases reported in Norway from
December 2021 to January 2022. We estimated a 73% reduced risk of hospitalisation
(adjusted hazard ratio: 0.27; 95% confidence interval: 0.20–0.36) for Omicron compared with
Delta
Risk of Guillain–Barré syndrome after vaccination against human
papillomavirus: a systematic review and meta-analysis, 1 January 2000
to 4 April 2020
27 Jan 2022
Background Guillain–Barré syndrome (GBS) is a rare autoimmune disease that can follow
viral infections and has in a few cases been linked to vaccinations. Pre-licensure clinical trials
did not observe an association between human papillomavirus (HPV) vaccination and GBS,
a post-marketing study from 2017 reported an increased relative risk
Variability in detection of SARS-CoV-2-specific antibody responses
following mild infection: a prospective multicentre cross-sectional study,
London, United Kingdom, 17 April to 17 July 2020
27 Jan 2022
Introduction Immunoassays targeting different SARS-CoV-2-specific antibodies are
employed for seroprevalence studies. The degree of variability between immunoassays
targeting anti-nucleocapsid (anti-NP; the majority) vs the potentially neutralising anti-spike
antibodies (including anti-receptor-binding domain; anti-RBD), particularly in mild or
asymptomatic disease, remains unclear
[back to top]
Hepatology
Post‐Vaccination COVID‐19 Infection is Associated with Reduced
Mortality in Patients With Cirrhosis
13 Jan 2022
Hepatology, Accepted Article.
Diverse facets of MDSC in different phases of chronic HBV infection:
impact on HBV specific T cell response and homing
09 Jan 2022
Hepatology, Accepted Article.[back to top]
Infection
Can microalbuminuria be an ındicator of renal ınvolvement in pediatric
Covid 19 patients?
30 Jan 2022
Abstract Background Proteinuria (both tubular and glomerular in origin) and its implications
are well-known features of adult patients with COVID19. However currently studies
addressing proteinuria and its role in the outcome of kidney and patients of pediatric COVID
19 is scarce
No evidence of harmful effects of steroids in severe exacerbations of
COPD associated with influenza
29 Jan 2022
Abstract Purpose COPD has large impact on patient morbidity and mortality worldwide.
Acute exacerbations (AECOPD) are mostly triggered by respiratory infections including
influenza. While corticosteroids are strongly recommended in AECOPD, they are potentially
harmful during influenza. We aimed to evaluate if steroid treatment for AECOPD due to
influenza may worsen outcomes
The rising of old foes: impact of lockdown periods on “non-SARS-CoV-
2” viral respiratory and gastrointestinal infections
25 Jan 2022
Abstract Background During COVID-19-related public health non-pharmaceutical prevention
measures, such as social distancing, lockdown periods and use of face masks, a decrease in
viral respiratory and gastroenterological infections was observed worldwide
Bedside risk prediction for positive follow-up blood culture in Gram-
negative bacilli bacteremia: for whom is follow-up blood culture useful?
21 Jan 2022
Abstract Purpose The value of follow-up blood culture (FUBC) in Gram-negative bacteremia
(GNB) management is controversial. We evaluated bedside risk predictors and their
probabilities of yielding positive FUBCs in GNB. Methods All adult patients with GNB in a
2700-bed tertiary center were retrospectively enrolled between January 2019 and December
2019
One-year evolution of DLCO changes and respiratory symptoms in
patients with post COVID-19 respiratory syndrome
21 Jan 2022
Abstract Purpose During a follow-up program of patients admitted for COVID-19 at our non-
ICU Unit, we found that 37% of them had decreased diffusing lung capacity for carbon
monoxide (DLCO) 3–6 months after discharge. This prospective observational study aimed
to evaluate the evolution of changes in DLCO and respiratory symptoms at the 1-year follow-
up visit
Correction to: Clinical features of gastroenteritis during a large
waterborne Campylobacter outbreak in Askøy, Norway
20 Jan 2022
[back to top]
International Journal of Medical Microbiology
Rectal swabs are a reliable method of assessing the colonic
microbiome
25 Jan 2022
Publication date: Available online 24 January 2022Source: International Journal of Medical
MicrobiologyAuthor(s): Greg Turner, Michael O’Grady, Daniel Hudson, Xochitl Morgan, Frank
Frizelle, Rachel PurcellVirulent Staphylococcus aureus Colonizes Pediatric Nares by Resisting
Killing of Human Antimicrobial Peptides
25 Jan 2022
Publication date: Available online 24 January 2022Source: International Journal of Medical
MicrobiologyAuthor(s): Ziyu Yang, Bijun Qiu, Danhong Cheng, Na Zhao, Yao Liu, Min Li,
Qian Liu
[back to top]
Infection Control & Hospital Epidemiology - FirstView Article
Development and evaluation of a structured guide to assess the
preventability of hospital-onset bacteremia and fungemia
28 Jan 2022
Published online by Cambridge University Press:
Association between prevalence of laboratory-identified Clostridioides
difficile infection (CDI) and antibiotic treatment for CDI in US acute-care
hospitals, 2019
24 Jan 2022
Published online by Cambridge University Press:
Evaluation of fidaxomicin use in community hospitals after a clinical
guideline change at a large health system and opportunities for
stewardship
24 Jan 2022
Published online by Cambridge University Press:
[back to top]
International Journal of Infectious Diseases
Contact tracing period and epidemiological characteristics of an
outbreak by SARS-CoV-2 Delta variant in Guangzhou
30 Jan 2022
Publication date: Available online 29 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Xiaowei Ma, Keyi Wu, Yongguang Li, Shunming Li, Lan Cao, Huaping
Xie, Jiazhen Zheng, Rui Zhou, Zelin Yuan, Zhiwei Huang, Jun Yuan, Xianbo Wu
Mediterranean spotted fever and peripheral facial nerve palsy: a rare
neurological complication
30 Jan 2022
Publication date: Available online 30 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Hayet Bouchaib, Achour Amrane, Jacques Sevestre, Idir Bitam, Phillipe
Parola
Disseminated hepatic and peritoneal hydatidosis mimicking acute
abdomen
30 Jan 2022
Publication date: Available online 30 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Mohamed Hajri, Sahir Omrani, Hafedh Mestiri, Rached Bayar
COVID-19 and Lassa fever in Nigeria: A deadly alliance?
30 Jan 2022
Publication date: Available online 30 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Salihu Sabiu Musa, Shi Zhao, Zainab Umar Abdullahi, Abdulrazaq Garba
Habib, Daihai He
Characteristics and Outcomes of COVID-19 in Reproductive-Aged
Pregnant and Non-Pregnant Women in Osaka, Japan
30 Jan 2022Publication date: Available online 29 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Ling Zha, Tomotaka Sobue, Atsushi Hirayama, Taro Takeuchi, Kenta
Tanaka, Yusuke Katayama, Sho Komukai, Takeshi Shimazu, Tetsuhisa Kitamura, COVID-19
Epidemiology Research Group of Osaka University
Treatment with Tocilizumab in Adult Patients with Moderate to Critical
COVID‐19 Pneumonia: A Single‐Center Retrospective Study
28 Jan 2022
Publication date: Available online 27 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Amanda Radulescu, Alexandru Istrate, Monica Muntean
Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A
Prospective Cohort Study
28 Jan 2022
Publication date: Available online 27 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Panyachot Buasroung, Tananchai Petnak, Prapaipim Liwtanakitpipat,
Sasisopin Kiertiburanakul
The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening
Asymptomatic Hospital Visitors in Low-incidence Settings
27 Jan 2022
Publication date: Available online 27 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Nymisha L. Boddeti, Ivan Berezowski, Dania Taylor, Dhruvil Prajapati,
Jigar Patel
Correspondence on “The Low Yield of SARS-CoV-2 Rapid Antigen
Testing in Screening Asymptomatic Hospital Visitors in Low-incidence
Settings”
27 Jan 2022
Publication date: Available online 27 January 2022Source: International Journal of Infectious
DiseasesAuthor(s): Liang En Wee, Edwin Philip Conceicao, Jean Xiang-Ying Sim, Indumathi
Venkatachalam, Limin Wijaya
[back to top]
Journal of Clinical Microbiology
Genomic epidemiology links Burkholderia pseudomallei from individual
human cases to B. pseudomallei from targeted environmental sampling
in Northern Australia
26 Jan 2022
Journal of Clinical Microbiology, Volume 0, Issue ja, -Not available-.
[back to top]
Journal of Hospital Infection
Community Respiratory Viruses and Healthcare-associated Infections:
epidemiological and clinical aspects
27 Jan 2022
Healthcare-associated infections (HAIs) impact morbidity, mortality, and hospitalization costs.
They usually have a bacterial aetiology, and it is still unknown the participation of viruses in
those instances. This study aimed to evaluate the prevalence and clinical findings in patients
with HAIs caused by respiratory viruses.
A Bayesian spatial-temporal model for prevalence estimation of a VRE
outbreak in a tertiary care hospital
25 Jan 2022
There was a nosocomial outbreak of vancomycin-resistant enterococci (VRE) in our hospital
from 1.1.2018 to 31.7.2020. The goals of the study were to describe weekly prevalence, and
to identify possible effects of the introduction of selected infection control measures.Clinical Characteristics and Microbiology of Nosocomial Enterococcal
Bloodstream Infections in a Tertiary-level Hospital: A Retrospective
Study, 2009-2017
23 Jan 2022
Enterococci are important pathogens causing nosocomial bloodstream infections (BSIs) and
cannot be treated with appropriate timely empirical antibiotics due to their natural resistance
to many kinds of antibiotics. The purpose of this study was to analyse the clinical
characteristics and microbiological features of nosocomial bloodstream infections caused by
Enterococci.
[back to top]
Journal of Infection
Routine molecular point-of-care testing for SARS-CoV-2 reduces
hospital-acquired COVID-19
30 Jan 2022
Timely recognition and management of COVID-19, caused by infection with the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is critical in preventing onward
transmission to other patients in hospital [1]. NHS data suggests that by May 2021 over
32,000 hospital-acquired COVID-19 cases had occurred with nearly 9000 associated deaths
[2]
Safety and Efficacy of the Covid-19 Vaccine in children andor
adolescents: A meta-analysis
30 Jan 2022
Since 2019, the COVID-19 epidemic has raged worldwide, with children and adolescents
accounting for a quarter of the world's population being greatly threatened. The safety and
effectiveness of the COVID-19 vaccine for children have been examined. At present, clinical
trials of COVID-19 vaccines for children are gradually increasing. The most common ones
are attenuated and inactivated vaccines
COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2
infections
30 Jan 2022
We read with interest the recent article of Hsu and colleagues [1], who concluded that
vaccination against coronavirus disease 2019 (COVID-19) is highly effective to lower the risk
of developing severe and/or life-threatening illness, but does not seem very efficient for
averting the likelihood of becoming infected by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and, therefore,
Corrigendum to “Prognosis of unexpected positive intraoperative
cultures in arthroplasty revision: A large multicenter cohort” [Journal of
Infection 83 (2021) 542–549]
29 Jan 2022
The authors regret that an author name was missing from their published article. This has
now been added and the author list above is correct.
Post-COVID-19 Fatigue among COVID-19 in patients discharged from
hospital: A meta-analysis
28 Jan 2022
Dear Editor,
Exploring the Recovery Curves for Long-term Post-COVID Functional
Limitations on Daily Living Activities: The LONG-COVID-EXP-CM
Multicenter Study
28 Jan 2022
To the EditorAn exploratory analysis of C-X-C motif chemokine ligand 10 as a new
biomarker of asymptomatic Leishmania infantum infection in Solid-
Organ Transplant Recipients
28 Jan 2022
Visceral leishmaniasis (VL) is a potentially serious complication for recipients of solid organ
transplants (SOT). The mortality attributable to such infection is thought to be around 3% and
the relapse rate may exceed 25% (1, 2)
Evaluation of disease severity during SARS-COV-2 reinfection, January
2020 to April 2021, England: an observational study
24 Jan 2022
The first documented case of confirmed SARS-Cov-2 reinfection was in Hong Kong in
August 2020. Reinfection status was ascertained by comparison of genetic sequences from
each episode.1, 2 Since then, multiple accounts of SARS-Cov-2 reinfections have been
reported worldwide.1-4
[back to top]
Journal of Infectious Diseases
Contribution of High Viral Loads, Detection of Viral Antigen and
Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2
Infectivity
24 Jan 2022
Felix Buder, Markus Bauswein, Clara L Magnus, Franz Audebert, Henriette Lang ... The
Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 190–198,
https://doi.org/10.1093/infdis/jiab415 In 79 respiratory samples from 59 patients, isolation of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) correlated significantly with
high viral loads and detection of viral
Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and
Clinical Outcomes in Children With Coronavirus Disease 2019
24 Jan 2022
Cameron Mertz, Rebecca Glowinski, Shira H Cohen, Sara Mertz, Fang Ye ... The Journal of
Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 208–213,
https://doi.org/10.1093/infdis/jiab491 In a cohort of 103 children and adolescents hospitalized
with COVID-19 with diverse clinical manifestations, SARS-CoV-2 RNAemia was detected in
26% of them, lasted for 6 (interquartile range, 2–9)
Estimation of SARS-CoV-2 Infection Fatality Rate by Age and
Comorbidity Status Using Antibody Screening of Blood Donors During
the COVID-19 Epidemic in Denmark
24 Jan 2022
Kathrine Agergård Kaspersen, Lotte Hindhede, Jens Kjærgaard Boldsen, Susan Mikkelsen,
Lasse Skafte Vestergaard ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15
January 2022, Pages 219–228, https://doi.org/10.1093/infdis/jiab566 The COVID-19 infection
fatality rate was low for citizens younger than 51 years without comorbidity (3.36 per 100000
infections)
Epidemiologic, Immunologic, and Virus Characteristics in Patients With
Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology
and Reverse-Transcription Polymerase Chain Reaction Testing
24 Jan 2022
Talya Shragai, Sarah E Smith-Jeffcoat, Mitsuki Koh, Marcos C Schechter, Paulina A
Rebolledo ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022,
Pages 229–237, https://doi.org/10
Combination of Clofazimine and Atovaquone as a Potent Therapeutic
Regimen for the Radical Cure of Babesia microti Infection in
Immunocompromised Hosts24 Jan 2022 Bumduuren Tuvshintulga, Thillaiampalam Sivakumar, Arifin Budiman Nugraha, Believe Ahedor, Enkhbaatar Batmagnai ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 238–242, https://doi.org/10.1093/infdis/jiab537 Abstract View article Supplementary data Occurrence and Distribution of Nonfalciparum Malaria Parasite Species Among Adolescents and Adults in Malawi 24 Jan 2022 Austin Gumbo, Hillary M Topazian, Alexis Mwanza, Cedar L Mitchell, Sydney Puerto- Meredith ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 257–268, https://doi.org/10.1093/infdis/jiab353 Using dried blood spots from the 2015–2016 Malawi Demographic and Health Survey, we assess spatial distribution of P. malariae, P. ovale spp., and P Increasing Frequency and Transmission of HIV-1 Non-B Subtypes Among Men Who Have Sex With Men in the Swiss HIV Cohort Study 24 Jan 2022 Jessy J Duran Ramirez, Tala Ballouz, Huyen Nguyen, Katharina Kusejko, Sandra E Chaudron ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 306–316, https://doi.org/10.1093/infdis/jiab360 The proportion of MSM with newly diagnosed HIV-1 non-B subtypes has strongly increased since 1990, reaching 34% of all MSM diagnosed in 2019 Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines 24 Jan 2022 Donna Ambrosino, Htay Htay Han, Branda Hu, Joshua Liang, Ralf Clemens ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 327–331, https://doi.org/10.1093/infdis/jiab574 The antibody-binding responses to the adjuvanted S- Trimer vaccine, SCB-2019 + CpG/alum, were compared with approved vaccines and accurately predicted success of the recently reported efficacy trial Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials 24 Jan 2022 Ying Huang, Brian D Williamson, Zoe Moodie, Lindsay N Carpp, Laurent Chambonneau ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 332–340, https://doi.org/10.1093/infdis/jiab342 In baseline-seropositive placebo recipients in 2 dengue vaccine efficacy trials, time-varying neutralizing antibody titer against dengue was a significant inverse correlate of Severe Acute Respiratory Syndrome Coronavirus 2–Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience 24 Jan 2022 Alfredo G Puing, Stephanie Ho, Paul Frankel, Bernard Tegtmeier, Abigail Martin ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 352–354, https://doi.org/10.1093/infdis/jiab406 Extract View article Cellular and Humoral Response, Six Months After Two Doses of BNT162b2 Messenger Ribonucleic Acid Coronavirus Disease 2019 Vaccination, in Residents and Staff of Nursing Homes for the Elderly 24 Jan 2022 Héctor Meijide Míguez, Miguel Ochando Gómez, Iñaki Montes García, Isabel M García Merino, Alejandro De La Torre The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 355–357, https://doi.org/10.1093/infdis/jiab546 Extract View article Corrigendum to: Staphylococcus aureus Decolonization of Mice With Monoclonal Antibody Neutralizing Protein A 24 Jan 2022
Xinhai Chen, Yan Sun, Dominique Missiakas, Olaf Schneewind The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Page 358, https://doi.org/10.1093/infdis/jiab438 Extract View article Erratum to: Clonality of HIV-1– and HTLV-1–Infected Cells in Naturally Coinfected Individuals 24 Jan 2022 Hiroo Katsuya, Lucy B M Cook, Aileen G Rowan, Anat Melamed, Jocelyn Turpin ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Page 359, https://doi.org/10.1093/infdis/jiab493 Extract View article Clofazimine for Babesiosis: Preclinical Data Support a Clinical Trial 24 Jan 2022 Edouard Vannier, Jeffrey A Gelfand The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 187–189, https://doi.org/10.1093/infdis/jiab538 Extract View article The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity 24 Jan 2022 Aleksandra Kovacevic, Rosalind M Eggo, Marc Baguelin, Matthieu Domenech de Cellès, Lulla Opatowski The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 199–207, https://doi.org/10.1093/infdis/jiab459 Coronavirus disease 2019 surveillance indicators may be affected by increased cocirculation of other respiratory viruses delaying control measure implementation Urban Particulate Matter Impairment of Airway Surface Liquid– Mediated Coronavirus Inactivation 24 Jan 2022 Emma M Stapleton, Jennifer L Welch, Erika A Ubeda, Jinhua Xiang, Joseph Zabner ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 214–218, https://doi.org/10.1093/infdis/jiab545 Primary human airway surface liquid (ASL) inactivates severe acute respiratory syndrome coronavirus 2 and human alphacoronavirus coronavirus 229E in vitro Deep Sequencing to Detect Diversity of Trypanosoma cruzi Infection in Patients Coinfected With Human Immunodeficiency Virus and Chagas Disease 24 Jan 2022 Natalie M Bowman, Sujata Balasubramanian, Robert H Gilman, Christian Parobek, Maritza Calderon ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 243–247, https://doi.org/10 The Effect of Intermittent Preventive Treatment of Malaria During Pregnancy and Placental Malaria on Infant Risk of Malaria 24 Jan 2022 Liana R Andronescu, Ankur Sharma, Ingrid Peterson, Martin Kachingwe, Witness Kachepa ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 248– 256, https://doi.org/10.1093/infdis/jiab351 In a cohort of infants born to mothers randomized to receive sulfadoxine-pyrimethamine or dihydroartemisinin-piperaquine to prevent malaria during pregnancy, we found no impact of Propagation of Activated B Cells by In Vitro Severe Fever With Thrombocytopenia Syndrome Virus Infection of Human Peripheral Blood Mononuclear Cells 24 Jan 2022 Yuji Wada, Sho Miyamoto, Shun Iida, Kaori Sano, Yuko Sato ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 269–281, https://doi.org/10.1093/infdis/jiab343 In vitro infection of human PBMCs with a tick-borne
hemorrhagic fever virus, SFTSV, stimulates propagation of activated B cells, which mimic the
virus target cells observed in SFTS patients, and are induced by
SARS-CoV-2 Interference of Influenza Virus Replication in Syrian
Hamsters
24 Jan 2022
Peter J Halfmann, Noriko Nakajima, Yuko Sato, Kenta Takahashi, Molly Accola ... The
Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 282–286,
https://doi.org/10.1093/infdis/jiab587 In hamsters, a previous infection with severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) interferes with a sequential infection with
influenza virus (H3N2 subtype)
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic
Human Immunodeficiency Virus–Infected Recipients of Long-term
Antiretroviral Treatment
24 Jan 2022
Andrés Esteban-Cantos, Rocio Montejano, Javier Rodríguez-Centeno, Gabriel Saiz-
Medrano, Rosa De Miguel ... The Journal of Infectious Diseases, Volume 225, Issue 2, 15
January 2022, Pages 287–294, https://doi.org/10.1093/infdis/jiab338 Epigenetic aging,
according to 3 different epigenetic clocks, did not accelerate in a cohort of long-term aviremic
HIV-infected adults after 4 years of follow-up
Menopause Is Associated With Immune Activation in Women With HIV
24 Jan 2022
Brandilyn A Peters, Xiaonan Xue, Lila A Sheira, Qibin Qi, Anjali Sharma ... The Journal of
Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 295–305,
https://doi.org/10.1093/infdis/jiab341 In women living with HIV on antiretroviral therapy,
menopause was associated with increased levels of innate immune activation plasma
biomarkers soluble CD14 and CD163, but not with biomarkers of
Clonality of HIV-1– and HTLV-1–Infected Cells in Naturally Coinfected
Individuals
24 Jan 2022
Hiroo Katsuya, Lucy B M Cook, Aileen G Rowan, Anat Melamed, Jocelyn Turpin ... The
Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 317–326,
https://doi.org/10.1093/infdis/jiab202 We investigated the mutual effect of HIV-1/HTLV-1
coinfection on their integration sites and the clonal expansion and found the degree of
oligoclonality of both HIV-1– and HTLV-1–infected
Early Changes in Interferon Gene Expression and Antibody Responses
Following Influenza Vaccination in Pregnant Women
24 Jan 2022
Raquel Giacomelli Cao, Lisa Christian, Zhaohui Xu, Lisa Jaramillo, Bennett Smith ... The
Journal of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 341–351,
https://doi.org/10.1093/infdis/jiab345 Abstract View article Supplementary data
Reply to Puing et al
24 Jan 2022
Ravindra Ganesh, Lindsey M Philpot, Dennis M Bierle, Raymund R Razonable The Journal
of Infectious Diseases, Volume 225, Issue 2, 15 January 2022, Pages 353–355,
https://doi.org/10.1093/infdis/jiab407 Extract View article
[back to top]
Journal of Virology Current Issue
Articles of Significant Interest In This Issue
26 Jan 2022
Journal of Virology, Volume 96, Issue 2, January 2022.
Tumor Susceptibility Gene 101 (TSG101) Contributes to Virion
Formation of Porcine Reproductive and Respiratory Syndrome Virus viaYou can also read
